Location History:
- Konigstein, Taunus, DE (1978)
- Konigstein all of, DE (1980)
- Konigstein, DE (1981 - 1989)
- Konigstein/Taunus, DE (1991 - 1994)
Company Filing History:
Years Active: 1978-1994
Title: The Innovations of Hans G Alpermann
Introduction
Hans G Alpermann is a notable inventor based in Königstein, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of corticoid compounds. With a total of 8 patents to his name, Alpermann's work has had a considerable impact on medical science.
Latest Patents
Alpermann's latest patents include innovative formulations such as corticoid-17-alkyl-carbonates substituted in the 17-position. This invention encompasses a process for their preparation and the pharmaceuticals that contain them. The corticoid-17-alkylcarbonates are characterized by a specific formula where various substituents can be modified to achieve desired effects. Additionally, he has developed 1-(1-aryl-2-hydroxyethyl)-imidazoles and their salts, which are used in medicaments with antimycotic and antidepressive properties.
Career Highlights
Hans G Alpermann is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has been instrumental in advancing the understanding and application of corticoid compounds in medicine. Alpermann's innovative spirit and dedication to research have positioned him as a key figure in his field.
Collaborations
Throughout his career, Alpermann has collaborated with esteemed colleagues such as Ulrich Stache and Werner Fritsch. These partnerships have fostered a collaborative environment that has led to groundbreaking advancements in pharmaceutical research.
Conclusion
Hans G Alpermann's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in medical science and improve therapeutic options for patients.